Objective To study the frequency of allele A of polymorphism PD‐1.3 of the PDCD1 gene in
patients with rheumatoid arthritis (RA) and its subsets, based on the presence of rheumatoid …

Objective The programmed death 1 (PD‐1) molecule is a negative regulator of T cells, and a
genetic association between PD‐1 and systemic lupus erythematosus and rheumatoid …

Objective The A allele of the PD1. 3 single‐nucleotide polymorphism (SNP) on the
programmed cell death gene PDCD1 was markedly more frequent in patients with systemic …

Objective To analyze the association of the PD‐1.3 polymorphism within the PDCD1 gene in
patients with systemic lupus erythematosus (SLE) from the homogeneous population in …

Systemic lupus erythematosus (SLE) is an autoimmune inflammatory disease with a
prevalence of 0.05–0.07% in women of European descent (1). Chronic inflammation in …

We evaluated the roles of five single-nucleotide polymorphisms (SNPs) within PDCD1, and
haplotypes defined by these SNPs, for the development of systemic lupus erythematosus …

Recently, a polymorphism in intron 4 (G/A) of the programmed cell death 1 (PDCD1) gene
was shown to be associated with systemic lupus erythematosus (SLE) risk in familial and …

Objective. Programmed cell death 1 (PD‐1) induces negative signals to T cells during
interaction with its ligands and is therefore a candidate gene in the development of …

Abstract The PD-1 (programmed death 1) molecule is a negative regulator of T cells. PDCD1
(programmed cell death 1) has been reported to have a genetic association in systemic …

A regulatory single nucleotide polymorphism (SNP) PD1. 3G/A located on programmed cell
death 1 (PDCD1) gene, was shown to be involved in susceptibility to systemic lupus …